Standout Papers
Citation Impact
Citing Papers
An Overview of Cyclophosphamide and Ifosfamide Pharmacology
1997
Hallmarks of Cancer: The Next Generation
2011 Standout
Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type
2002
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Pancreatic cancer
2004 Standout
Testicular Germ-Cell Cancer
1997 Standout
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Transmission of donor melanoma by organ transplantation
2010
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
2004
Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients
2006
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)
1994
The biology and management of non-small cell lung cancer
2018 StandoutNature
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Acute graft-vs-host disease
2001
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Pancreatic cancer
2016 Standout
Systemic sclerosis
2017 Standout
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Esophageal Cancer
2003 Standout
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Preoperative chemotherapy for non-small cell lung cancer
2001
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Lung cancer: current therapies and new targeted treatments
2016 Standout
Pancreatic Adenocarcinoma
2014 Standout
Chemotherapy-Induced Anemia in Adults: Incidence and Treatment
1999
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Pre-eclampsia
2005 Standout
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial
2005
Drug-induced heart failure
1999
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Nasopharyngeal carcinoma
2015 Standout
Graft-versus-host disease
2009 Standout
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients
2000
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
1996
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Early Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with Cancer
1997
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
2004 Standout
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Chemotherapy as treatment of primary and recurrent small cell lung cancer
2001
Hematopoietic Stem-Cell Transplantation
2006 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer
2000
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
2001
Myocarditis
2000 Standout
Pancreatic Cancer
2010 Standout
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
2001 Standout
Clinical imaging of cancer metastasis
2000
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer
2015
Functional activity of murine CD34+and CD34− hematopoietic stem cell populations
1999
Pre-eclampsia
2015 Standout
Anemia of Chronic Disease
2005 Standout
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival
2000
Pancreatic cancer
2011 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Cancer of the Ovary
2004 Standout
Effect of Ions on the Structure of Water: Structure Making and Breaking
2009 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation
2003
Oncogenic interaction between BCR-ABL andNUP98-HOXA9 demonstrated by the use of an in vitro purging culture system
2002
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
1999
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
1999
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
2002
Paclitaxel in Advanced Urothelial Carcinoma: Its Role in Patients with Renal Insufficiency and as Salvage Therapy
1996
Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia
2005
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma
2002
Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy
2015
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
2014
“Low-Risk” Prediction Rule for Pediatric Oncology Patients Presenting With Fever and Neutropenia
2000
Respiratory syncytial virus infection—risk factors for hospital admission: a case‐control study
2003
Rapid Engraftment Without Significant Graft-Versus-Host Disease After Allogeneic Transplantation of CD34+ Selected Cells From Peripheral Blood
1997
Study of gallium(III) nitrate hydrate and aqueous solutions: Raman spectroscopy and ab initio molecular orbital calculations of gallium(III) water clusters
2002
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Detection of leukemic cells in the CD34+CD38− bone marrow progenitor population in children with acute lymphoblastic leukemia
2001
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2015
Cytokine-induced radiation protection and sensitization
1996
Works of R Gonin being referenced
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.
1993
Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma.
1994
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
1995
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
1994
Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
1992
Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial.
1991
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
2009
Protective Activity of a Human Respiratory Syncytial Virus Immune Globulin Prepared from Donors Screened by Microneutralization Assay
1992
Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
1992
Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells
1998
Neoadjuvant Treatment of Stage IIIA Non-Small Cell Lung Cancer Long-Term Results
1994
Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
1995
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.
1992
Late relapse of testicular cancer.
1995
Predicting the risk of bacteremia in childen with fever and neutropenia.
1996
Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma.
1997
Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.
1996
The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension.
1991
Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
1993
Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation
1993